Hemab Therapeutics Employee Directory
Biotechnology ResearchHovedstaden, Denmark51-200 Employees
Hemab Therapeutics is a clinical-stage biotechnology company focused on preventive therapies for serious, underserved bleeding and thrombotic disorders. It advances monoclonal and bispecific antibody-based candidates designed to prevent bleeding events or thrombotic complications in patients with high unmet medical needs, including conditions such as Glanzmann thrombasthenia, factor VII deficiency, Bernard-Soulier syndrome, and von Willebrand disease. The company operates from Cambridge, Massachusetts and Copenhagen, Denmark, and has outlined a plan to advance five clinical assets by 2025 under its Hemab 1-2-5 strategy. This positions Hemab within the biotechnology research sector as a developer focused on prophylactic biologics for rare clotting disorders. In 2025, Hemab appointed Anant Murthy as Chief Operating Officer, reflecting organizational growth alongside its clinical development efforts.